January 5, 2018
We’ve all seen and used the American College of Cardiology 10-year atherosclerotic cardiovascular disease (ASCVD) risk calculator. There are several modifiable risk factors such as blood pressure, cholesterol, and smoking status that, if addressed, can lower ASCVD risk. But are there other modifiable risk factors that we are failing to account for and might be able to address? New evidence suggests systemic inflammation may be one.
Guest Authors: Ian Hatlee, Pharm.D and Scott Pearson, Pharm.D.
Music by Good Talk
February 26, 2016
With over 75% of people using mobile phones worldwide, text messaging might be a simple, cost-effective platform to encourage lifestyle changes. Several healthcare-related applications and mobile phone text messaging systems have already been designed; yet, very few have undergone rigorous testing to confirm clinical benefit. The investigators of the Tobacco, Exercise, and Diet Messages (TEXT ME) trial designed a text message-based intervention to encourage lifestyle modifications and evaluated its impact on cardiovascular risk in patients with established CHD. The TEXT ME study provides robust findings to support a simple, inexpensive intervention to modify cardiovascular risk … at least over the short term.
February 10, 2016
The debate over the intensity of blood pressure
(BP) lowering for patients with hypertension has been going on for decades. Additional fuel to the fire was recently added
with the early halt and publication of the Systolic Blood Pressure Intervention
Trial (SPRINT). So “how low should
you go” for patients with high BP? Do lower BP goals reduce CV outcomes and
death, particularly in patients at high risk?
Do they cause greater adverse effects? Or perhaps even worsen CV outcomes?
These questions were examined in SPRINT.
July 28, 2015
How well do cardiovascular disease risk calculators really perform? Do they over or underestimate risk? Should we rely on them to make treatment decisions?